Key statistics
On Monday, Orion Oyj (ORNAV:HEX) closed at 53.20, -5.00% below its 52-week high of 56.00, set on Mar 05, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 53.00 |
---|---|
High | 53.30 |
Low | 52.40 |
Bid | 53.20 |
Offer | 53.20 |
Previous close | 53.00 |
Average volume | 10.43k |
---|---|
Shares outstanding | 141.13m |
Free float | 126.69m |
P/E (TTM) | 22.23 |
Market cap | 7.38bn EUR |
EPS (TTM) | 2.36 EUR |
Annual div (ADY) | 1.64 EUR |
---|---|
Annual div yield (ADY) | 3.06% |
Div ex-date | Oct 15 2024 |
Div pay-date | Oct 23 2024 |
Next div ex-date | Apr 04 2025 |
Next div pay-date | Apr 14 2025 |
Data delayed at least 15 minutes, as of Mar 10 2025 17:00 BST.
More ▼
Announcements
- Orion Oyj: 191 911 oman B-osakkeen luovutus 10.3.2025
- Orion Corporation: Transfer of 191,911 own B shares on 10 March 2025
- Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
- Orion Oyj: Arvopaperimarkkinalain 9. luvun 10. pykälän mukainen ilmoitus (BlackRock, Inc.)
- Orion to open new Biologics R&D Centre in Cambridge, UK in 2025 to support global growth strategy, considers reorganizing some work in Turku
- Orion avaa uuden biologisten lääkkeiden T&K-keskuksen Cambridgeen vuonna 2025 tukemaan globaalia kasvustrategiaa – yhtiö harkitsee joidenkin työtehtävien uudelleenjärjestelyä Turussa
- Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
- Orion Oyj: Arvopaperimarkkinalain 9. luvun 10. pykälän mukainen ilmoitus (BlackRock, Inc.)
- Orion and Aiforia extend collaboration to preclinical study evaluations
- Orion ja Aiforia laajentavat yhteistyötään prekliinisten tutkimusten arviointiin
More ▼